Alpha Teknova Inc. Company Profile
NASDAQ: TKNOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Alpha Teknova at a glance
Alpha Teknova Inc. (NASDAQ: TKNO) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector headquartered in Hollister, CA. Alpha Teknova is led by Mr. Stephen Gunstream and employs about 158 people. The company's shares have traded publicly since 2021.
At a market capitalization of $480.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001850902, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Alpha Teknova do?
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Business description based on the company's public filings.
Company information
- Legal name
- Alpha Teknova Inc.
- Ticker
- NASDAQ: TKNO
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CEO
- Mr. Stephen Gunstream
- Employees
- 158
- Headquarters
- 2451 Bert Dr., Hollister, CA, United States
- Phone
- 831 637 1100
- Website
- teknova.com
- IPO year
- 2021
- Market cap
- $479.95M
- SEC CIK
- 0001850902
- Latest annual report
- 10-K · Mar 2, 2026
Companies similar to Alpha Teknova
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MYGNMyriad Genetics Inc. | 5.46 | -1.44% | $523.74M | vs TKNO |
| QDELQuidelOrtho Corporation | 8.32 | -6.73% | $570.86M | vs TKNO |
| QUITAchieve Life Sciences Inc. | 5.56 | -5.28% | $573.25M | vs TKNO |
| NNNNAnbio Biotechnology Class A | 3.32 | -9.04% | $145.72M | vs TKNO |
| ICCCImmuCell Corporation | 10.92 | -2.41% | $99.28M | vs TKNO |
| IMDXInsight Molecular Diagnostics Inc. | 1.97 | +18.67% | $80.88M | vs TKNO |
| VNRXVolitionRX Limited | 0.1621 | -1.58% | $5.85M | vs TKNO |
| TRIBTrinity Biotech plc ADR | 6.24 | +13.76% | $5.07M | vs TKNO |